Neurocrine Biosciences Inc. logo

Neurocrine Biosciences Inc.

NBIX | NASDAQ
Chart Builder DCF Calculator
$145.87
-$0.23 (-0.16%)
Nov 2, 2026, 2:09 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
478.6M 341.3M 249.7M 154.5M 89.6M 407.3M
Depreciation & Amortization
30.1M 27.1M 21.3M 15.6M 10.9M 8.6M
Stock-Based Compensation
217.9M 195.5M 194.3M 173.1M 134.2M 100M
Other Working Capital
97M 39.7M 112.1M 97.4M 47.6M 3.3M
Other Non-Cash Items
19.5M 173.8M -46.9M 44.5M 800K 61.2M
Deferred Income Tax
165.4M -123.1M -56.7M 19.1M 4.3M -310.7M
Change in Working Capital
-128.8M -19.2M 28.2M -67.4M 16.7M -37.9M
Operating Cash Flow
782.7M 595.4M 389.9M 339.4M 256.5M 228.5M
Capital Expenditures
-34M -38.2M -28.3M -16.5M -23.4M -10.9M
Cash Acquisitions
n/a n/a n/a -42.7M n/a n/a
Purchase of Investments
-1.32B -1.06B -1.41B -628.9M -804.7M -735.5M
Sales Maturities Of Investments
1.09B 967.5M 972.4M 511M 697.9M 750.5M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-264.4M -126.8M -467.1M -177.1M -130.2M 4.1M
Debt Repayment
n/a -308.8M n/a -279M -100K -186.9M
Common Stock Repurchased
-167.7M -300M n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a
Financial Cash Flow
-38.3M -486.7M 65.3M -234.3M 27.4M -157.8M
Net Cash Flow
480M -18.1M -11.6M -73.3M 153.7M 74.8M
Free Cash Flow
748.7M 557.2M 361.6M 322.9M 233.1M 217.6M
Adj. Free Cash Flow
530.8M 361.7M 167.3M 149.8M 98.9M 117.6M
Maintenance CapEx
n/a n/a n/a n/a -12.4M n/a
Growth CapEx
-34M -38.2M -28.3M -16.5M -11M -10.9M
Owner Earnings
782.7M 595.4M 389.9M 339.4M 244.1M 228.5M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.